9:22 AM
Leo Group India
| ||
| SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee Bill MarketWatch (press release) The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates (SOCMA), today commended the Senate for approving the Food and Drug Administration Safety and Innovation Act (S. 2516), bringing the nation ... See all stories on this topic » | ||
| Takeda Pharmaceutical: To Acquire Brazil's Multilab Industria For BRL500M In Cash Wall Street Journal TOKYO (Dow Jones)--Takeda Pharmaceutical Co. (4502.TO) said Friday it will acquire Brazil's Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for BRL500 million ($246 million) in an all-cash deal, as it seeks to tap into emerging market ... See all stories on this topic » | ||
| Pharmaceutical Preparations Manufacturing in the UK Industry Market Research ... San Francisco Chronicle (press release) The UK is the eighth-largest pharmaceutical market in the world. As such, the industry commands important positions in the local economy (with the overall pharmaceutical sector being the third-largest contributor to UK economic growth) and the global ... See all stories on this topic » | ||
| Pharmaceutical Industry Labor Management Association (PILMA) Applauds Senate's ... Sacramento Bee By Pharmaceutical Industry Labor-Management Association WASHINGTON, May 24, 2012 -- /PRNewswire-USNewswire/ -- The member companies and unions of the Pharmaceutical Industry Labor Management Association (PILMA) applaud the Senate's 96 to 1 vote today ... See all stories on this topic » | ||
| 254 Pharmaceutical Firms Found To Produce Unsafe Gel Capsules In China Bernama BEIJING, May 25 (Bernama) -- China's food and drug watchdog announced on Friday that 254 pharmaceutical enterprises or 12.7 percent of all capsule makers in the country were found to be producing unsafe drug capsules during a month-long inspection ... See all stories on this topic » | ||
| Sun Pharma's Israeli arm Taro doubles net profit Livemint Mumbai: Drug maker Sun Pharmaceutical Industries Ltd's Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the ... See all stories on this topic » | ||
| Takeda to Buy Multilab to Gain Sales Network in Brazil Bloomberg Takeda Pharmaceutical Co. (4502), Asia's largest drugmaker, agreed to buy closely held Multilab Industria e Comercio de Productos Farmaceuticos Ltda. for 500 million reais ($246 million) to gain a sales network in Brazil. See all stories on this topic » | ||
| Simmons Named CEO of Pharmaceutical Product Development Private Equity Hub (press release) Wilmington, NC-based Pharmaceutical Product Development LLC has named David Simmons chairman and CEO. He joins from Pfizer Inc., where he served as president and general manager of the emerging markets and established products business units. See all stories on this topic » | ||
| ||
| Pharmaceuticals for flat duty on raw material import Pakistan Observer Islamabad—Leading multinational pharmaceutical companies have proposed a flat customs duty rate of 10 percent or below on the import of raw materials and pharmaceutical active ingredients subjected to higher rate of duty under the tariff ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment